Cargando…
TIMELESS is a key gene mediating thrombogenesis in COVID-19 and antiphospholipid syndrome
Abnormal coagulation and increased risk of thrombosis are some of the symptoms associated with COVID-19 severity. Anti-phospholipid antibodies (aPLs) present in critically ill COVID-19 patients contribute to systemic thrombosis. The aim of this study was to identify key common genes to characterize...
Autores principales: | Zhang, Wenjing, Di, Longjiang, Liu, Zhongshuang, sun, Qi, Wu, Yan, Wang, Nuan, Jin, Meili, Gao, Lingling, Zhang, Mengyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568514/ https://www.ncbi.nlm.nih.gov/pubmed/36241659 http://dx.doi.org/10.1038/s41598-022-21694-3 |
Ejemplares similares
-
Timeless
por: Schuur, Diane
Publicado: (1986) -
Evidence of Thrombogenesis Recurrence Induced by IgA Antiphospholipid Antibody β2 Glycoprotein I-Dependent in Early Adulthood
por: Yacoub, Mirna S, et al.
Publicado: (2022) -
Ferroptosis of Endothelial Cells Triggered by Erythrophagocytosis Contributes to Thrombogenesis in Uremia
por: Li, Zhanni, et al.
Publicado: (2023) -
P1016: POLYCYTHEMIA VERA AND IMMUNE THROMBOGENESIS
por: Cacciola, R., et al.
Publicado: (2022) -
The Complex Relation between Atrial Cardiomyopathy and Thrombogenesis
por: D’Alessandro, Elisa, et al.
Publicado: (2022)